The analysis of the correlation between EYA2 expression and clinical pathological features revealed that the EYA2high phenotype was significantly associated with tumor size less than 5 cm (P = 0.001), Barcelona Clinic Liver Cancer (BCLC) stage with 0–A (P = 0.016) and tumor differentiation with I–II (P = 0.048) (Table 1). Here, EYA2 is linked to liver cancer.